Malik Alexa, Winchester Mae-Lan, Gorman Kelly, Parrott Jessica, Parrish Marc
Kansas University School of Medicine, Kansas University Medical Center, Kansas City, Kansas, USA.
Division of Maternal-Fetal Medicine, Kansas University Medical Center, Kansas City, Kansas, USA.
J Obstet Gynaecol Res. 2021 Apr;47(4):1589-1593. doi: 10.1111/jog.14699. Epub 2021 Feb 9.
Left ventricular assist devices have emerged as a safe and effective therapy for end-stage heart failure patients. However, little is known about the safety of these devices during pregnancy. We describe a 23-year-old woman who received a left ventricular device for nonischemic cardiomyopathy of uncertain origin. She became pregnant approximately 1 year later. With close monitoring of her hemodynamic parameters, she was able to achieve a gestational age of 34 weeks, at which time she delivered a healthy male infant by cesarean delivery. Pregnancies in women with left ventricular assist devices may be successful, but remain medically challenging and complex pregnancies. Close multidisciplinary involvement and frequent assessment of device parameters during pregnancy is warranted.
左心室辅助装置已成为治疗终末期心力衰竭患者的一种安全有效的疗法。然而,对于这些装置在孕期的安全性却知之甚少。我们描述了一名23岁的女性,她因不明原因的非缺血性心肌病接受了左心室装置。大约1年后她怀孕了。通过密切监测其血流动力学参数,她成功妊娠至34周,此时通过剖宫产分娩出一名健康男婴。植入左心室辅助装置的女性怀孕可能会成功,但仍然是具有医学挑战性且复杂的妊娠。孕期需要多学科密切参与并频繁评估装置参数。